[PDF][PDF] Appraising ultra-orphan drugs: is cost-per-QALY appropriate? A review of the evidence
A Towse, M Garau - Consulting Report, 2018 - ohe.org
In April 2017, following a public consultation, NICE changed the method for appraising
drugs and other health technologies reviewed through its Highly Specialised Technology …
drugs and other health technologies reviewed through its Highly Specialised Technology …